Oxford Science Enterprises is an independent investment company that finds, funds, and builds transformational science and technology companies emerging from Oxford research.
The financing round was led by Oxford Science Enterprises and will support market expansion in the UK, EU, and United States.
"We are thrilled that five successful institutional investors participated in the financing round which validates the vast clinical and business potential of Caristo’s innovations"
The Oxford spinout secured £9.2m from new and existing backers to scale its smart hot water technology.
"Mixergy is launching a new integrated heat pump cylinder in the Spring, which uses our top-down heating technology, with a small heat pump attached to the cylinder. It will heat water 10x faster than conventional integrated heat pump cylinders (usable hot water in under 30 min), and connect to the grid."
The oversubscribed round was led by Bosch Ventures with backing from Porsche SE and British Patient Capital.
"The support of leading technology investors enables us to realise our vision of a quantum computer built using standard foundry processes. This support, along with the continuing UK national quantum programme and European initiatives, provides a step-change in our capabilities. We have assembled a world leading team and with the funding and support in place, we are ready to scale and deliver on our vision."
The Series A round was led by Oxford Science Enterprises and Braavos Investment Advisers to support company expansion.
"Through its unique approach, developed by some of the world’s best minds in the quantum space, Oxford Ionics is laying the foundations to finally make quantum computing a scalable, integrable and viable option. Building on more than a decade at the forefront of this sector, Chris, Tom and the team have been able to demonstrate, time and again, that their work in the lab can, and will, extend to the real world and we’re thrilled to be joining them on this journey."
The round was backed by M&G Investments alongside existing supporters Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners.
"The Osler Origin platform has the potential to transform healthcare by enabling anyone, anywhere, to access, understand, and act on their healthcare information. This new investment allows us to advance the Osler Origin towards market, and to realise our vision."
